Disulfiram induced reversible hypertension: A prospective case study and brief review

Disulfiram (DSF) is one of the recommended aids in the management of alcohol dependence. Hypertension may be a clinically significant, dose-dependent, and usually reversible adverse event of DSF therapy. We report 6 month prospective study of normotensive case of comorbid alcohol and tobacco depende...

Full description

Bibliographic Details
Main Authors: Ranganath R Kulkarni, Bhavya K Bairy
Format: Article
Language:English
Published: SAGE Publishing 2013-01-01
Series:Indian Journal of Psychological Medicine
Subjects:
Online Access:http://www.ijpm.info/article.asp?issn=0253-7176;year=2013;volume=35;issue=2;spage=217;epage=219;aulast=Kulkarni
_version_ 1819125410792734720
author Ranganath R Kulkarni
Bhavya K Bairy
author_facet Ranganath R Kulkarni
Bhavya K Bairy
author_sort Ranganath R Kulkarni
collection DOAJ
description Disulfiram (DSF) is one of the recommended aids in the management of alcohol dependence. Hypertension may be a clinically significant, dose-dependent, and usually reversible adverse event of DSF therapy. We report 6 month prospective study of normotensive case of comorbid alcohol and tobacco dependence that developed reversible stage-II hypertension within 2-4 weeks of DSF therapy. We suggest that regular monitoring of blood pressure at least fortnightly for 1 st 3 months, followed by monthly for next 3 months, and later once in 3 months, may possibly detect "silent" adverse event of DSF - hypertension.
first_indexed 2024-12-22T07:39:42Z
format Article
id doaj.art-b2f8c55ba347480eb40ccfe3469d59d4
institution Directory Open Access Journal
issn 0253-7176
language English
last_indexed 2024-12-22T07:39:42Z
publishDate 2013-01-01
publisher SAGE Publishing
record_format Article
series Indian Journal of Psychological Medicine
spelling doaj.art-b2f8c55ba347480eb40ccfe3469d59d42022-12-21T18:33:47ZengSAGE PublishingIndian Journal of Psychological Medicine0253-71762013-01-0135221721910.4103/0253-7176.116263Disulfiram induced reversible hypertension: A prospective case study and brief reviewRanganath R KulkarniBhavya K BairyDisulfiram (DSF) is one of the recommended aids in the management of alcohol dependence. Hypertension may be a clinically significant, dose-dependent, and usually reversible adverse event of DSF therapy. We report 6 month prospective study of normotensive case of comorbid alcohol and tobacco dependence that developed reversible stage-II hypertension within 2-4 weeks of DSF therapy. We suggest that regular monitoring of blood pressure at least fortnightly for 1 st 3 months, followed by monthly for next 3 months, and later once in 3 months, may possibly detect "silent" adverse event of DSF - hypertension.http://www.ijpm.info/article.asp?issn=0253-7176;year=2013;volume=35;issue=2;spage=217;epage=219;aulast=KulkarniAdverse eventalcohol dependencedisulfiramhypertension
spellingShingle Ranganath R Kulkarni
Bhavya K Bairy
Disulfiram induced reversible hypertension: A prospective case study and brief review
Indian Journal of Psychological Medicine
Adverse event
alcohol dependence
disulfiram
hypertension
title Disulfiram induced reversible hypertension: A prospective case study and brief review
title_full Disulfiram induced reversible hypertension: A prospective case study and brief review
title_fullStr Disulfiram induced reversible hypertension: A prospective case study and brief review
title_full_unstemmed Disulfiram induced reversible hypertension: A prospective case study and brief review
title_short Disulfiram induced reversible hypertension: A prospective case study and brief review
title_sort disulfiram induced reversible hypertension a prospective case study and brief review
topic Adverse event
alcohol dependence
disulfiram
hypertension
url http://www.ijpm.info/article.asp?issn=0253-7176;year=2013;volume=35;issue=2;spage=217;epage=219;aulast=Kulkarni
work_keys_str_mv AT ranganathrkulkarni disulfiraminducedreversiblehypertensionaprospectivecasestudyandbriefreview
AT bhavyakbairy disulfiraminducedreversiblehypertensionaprospectivecasestudyandbriefreview